Abstract
The lockdown introduced in Georgia on November 28, 2020 brought positive results. There were clearly positive tendencies in the spread of COVID-19 to February - first half of March 2021. However, in April-May 2021 there was a significant deterioration in the epidemiological situation. From June to August 2021, the epidemiological situation with Covid-19 in Georgia became very difficult.
In this work results of the next statistical analysis of the daily data associated with New Coronavirus COVID-19 infection of confirmed (C), recovered (R), deaths (D) and infection rate (I) cases of the population of Georgia in the period from June 01, 2021 to August 31, 2021 are presented. It also presents the results of the analysis of two-week forecasting of the values of C, D and I. As earlier, the information was regularly sent to the National Center for Disease Control & Public Health of Georgia and posted on the Facebook page https://www.facebook.com/Avtandil1948/.
The analysis of data is carried out with the use of the standard statistical analysis methods of random events and methods of mathematical statistics for the non-accidental time-series of observations. In particular, the following results were obtained.
Georgia’s ranking in the world for Covid-19 monthly mean values of infection and deaths cases in summer 2021 (per 1 million population) was determined. Among 159 countries with population ≥ 1 million inhabitants in August 2021 Georgia was in the 1 place on new infection cases and on Death.
A comparison between the daily mortality from Covid-19 in Georgia in summer 2021 with the average daily mortality rate in 2015-2019 shows, that the largest share value of D from mean death in 2015-2019 was 66.0 % (26.08.2021 and 31.08.2021), the smallest 6.0 % (09.07.2021).
The statistical analysis of the daily and decade data associated with coronavirus COVID-19 pandemic of confirmed, recovered, deaths cases and infection rate of the population of Georgia are carried out. Maximum daily values of investigation parameters are following: C = 6208 (17.08.2021), R = 6177 (29.08.2021), D = 79 (26.08.2021 and 31.08.2021), I = 13.0 % (17.08.2021). Maximum mean decade values of investigation parameters are following: C = 5019 (2 Decade of August 2021), R = 4822 (3 Decade of August 2021), D = 69 (3 Decade of August 2021), I = 10.88 % (2 Decade of August 2021).
It was found that as with September 2020 to February 2021 and in spring 2021 [7,8], from June to August 2021 the regression equations for the time variability of the daily values of C, R and D have the form of a tenth order polynomial.
Mean values of speed of change of confirmed -V(C), recovered - V(R), deaths - V(D) and infection rate V(I) coronavirus-related cases in different decades of months in the summer 2021 were determined. Maximum mean decade values of investigation parameters are following: V(C) = +134 cases/day (1 Decade of August 2021), V(R) = +134 cases/day (2 Decade of August 2021), V(D) = +2.4 cases/day (3 Decade of August 2021), V(I) = + 0.25 %/ day (1 decades of August 2021).
Cross-correlations analysis between confirmed COVID-19 cases with recovered and deaths cases shows, that the maximum effect of recovery is observed 19 days after infection (RC=0.95), and deaths - after 16 and 18 days (RC=0.94). In Georgia in the summer 2021, the duration of the impact of the delta variant of the coronavirus on people (recovery, mortality) could be up to two months.
Comparison of real and calculated predictions data of C, D and I in Georgia are carried out. It was found that in summer 2021 two-week daily and mean two-week real values of C, D and I practically fall into the 67% - 99.99% confidence interval of these predicted values.
With September 1, 2021, it is started monthly forecasting of C, D and I values.
As earlier, the comparison of data about C and D in Georgia (GEO) with similar data in Armenia (ARM), Azerbaijan (AZE), Russia (RUS), Turkey (TUR) and in the World (WRL) is also carried out.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This article is a preprint and has not been certified by peer review [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Clinical Protocols
https://www.facebook.com/Avtandil1948/
Funding Statement
Budget financing
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
https://www.soothsawyer.com/john-hopkins-time-series-data-with-us-state-and-county-city-detail-historical/; https://data.humdata.org/dataset/total-covid-19-tests-performed-by-country https://stopcov.ge
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Source(s) of support: Nil.
Conflicting Interest – No.
